Halozyme Therapeutics, Inc. (HALO) Earnings
NASDAQ·Healthcare·Biotechnology
$69.64
-1.53%
Mkt Cap $8.48B
EPS — Estimate vs Actual
Mkt Cap
$8.48B
P/E
27.97
Fwd P/E
7.47
P/S
6.07
Rev TTM
—
EPS TTM
$2.49
NASDAQ·Healthcare·Biotechnology
$69.64
-1.53%
Mkt Cap $8.48B
Mkt Cap
$8.48B
P/E
27.97
Fwd P/E
7.47
P/S
6.07
Rev TTM
—
EPS TTM
$2.49